{"disease":{"id":"postbariatric-hypoglycemia","name":"postbariatric hypoglycemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06896682","title":"Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Esbjerg Hospital - University Hospital of Southern Denmark","has_results":false},{"nct_id":"NCT06036784","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"MBX Biosciences","has_results":false},{"nct_id":"NCT03373435","title":"Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Eiger BioPharmaceuticals","has_results":true},{"nct_id":"NCT05721729","title":"Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Vogenx, Inc.","has_results":false},{"nct_id":"NCT07029412","title":"Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"MBX Biosciences","has_results":false},{"nct_id":"NCT05541939","title":"Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Vogenx, Inc.","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}